Preventing obesity in children with acute lymphoblastic leukaemia
Part of Blood & lymphatic, Cancer, Hormones & metabolism, Immune system & allergy clinical trials.
This study looks at ways to prevent weight gain and obesity in children and young people being treated for acute lymphoblastic leukaemia (ALL). It aims to help them stay healthier during and after cancer treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- The child or young person must be between 5 and 21 years old.
- They must have acute lymphoblastic leukaemia (ALL) that is either newly diagnosed or has come back after treatment.
- Treatment must be aimed at curing the leukaemia, not just relieving symptoms.
- They must be enrolled in the ALLTogether study within two weeks of joining that study.
- Care must be at one of the two specific hospitals: Bristol (UK) or Madrid (Spain).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a bilingual, online program to help children and teens who have ALL (a type of leukemia) stay at a healthy weight during the maintenance phase of treatment. It may help lower the chance of gaining too much weight while on chemotherapy.
This study tests whether a special diet (calorie restriction) and increased physical activity can make chemotherapy work better for young people with B-ALL. Participants will follow a monitored diet and exercise plan during their first month of treatment.
This study helps childhood leukemia survivors avoid unhealthy weight gain during and after maintenance chemotherapy. It uses family-based counseling and exercise to promote healthy habits.
This study helps families of children with leukemia build healthy habits during treatment. It focuses on weight management and nutrition support after the first phase of therapy.
This trial tests whether adding a structured diet and exercise program during your hospital stay for newly diagnosed ALL can help your recovery. You must have a specific type of ALL and be receiving a certain chemotherapy regimen.
This Phase 3 trial studies a treatment plan for people up to age 45 who are newly diagnosed with B-cell or T-cell acute lymphoblastic leukemia (ALL). The goal is to see whether the study treatment improves outcomes compared with standard approaches.
Hear when a new Diet Intervention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.